Si le français est votre langue préférée, cliquez ici!

Select the BD Nexiva™ Closed IV Catheter to meet your organization’s infusion needs

Discover the difference of a closed PIVC system

BD Nexiva™ IV catheter dwells longer

Median dwell time for BD Nexiva™ IV catheters versus the open-system catheters studied in a randomized trial of PIVCs in place for more than 24 hours.⁸
A longer dwell time, paired with clinically indicated replacement of PIVCs, can result in:

• Significant reduction in healthcare resource use such as equipment and staff time⁶
• Minimized number of restarts and costs⁷
• Increased patient satisfaction⁷

BD Nexiva™ IV catheter reduces complications

Reduces manipulations

Integrated extension tubing and stabilization platform^† reduce manipulations and movement at the site that may lead to dislodgement^‡ and phlebitis^1,10

Reduces accidental dislodgement

Clinically demonstrated to reduce accidental dislodgement^10‡ and complies with the Infusion Therapy Standards of Practice and CDC guidelines for catheter stabilization^3,4

Lessens blood exposure

98% reduced blood exposure during insertion due to the BD Nexiva™ IV catheter preassembled system^10*

Lowers chance of mechanical phlebitis

Proprietary BD Vialon™ catheter material softens up to 70% in the vein, enabling longer dwell times and reducing the chance of mechanical phlebitis by up to 50%^11§

The BD Nexiva™ closed IV catheter system is the only all-in-one PIVC system shown to preserve sites for longer^(lopez)

6 days versus 4 days median dwell time versus an open system studied in a randomized trial of PIVCs in place for more than 24 hours¹
May reduce delays in treatment and costs^1,7,20
Makes treating patients safer, compliant with standards and guidelines^1,2,4,20
The BD portfolio of IV technologies has solutions that help provide significantly better care

If 35-50% of PIVCs fail¹, what is causing these failures?

Infection

The presence and growth of a pathogenic micro-organism(s) having a local or systemic effect³.

Phlebitis

Inflammation of a vein⁴.

Occlusion

Obstruction of a vascular access device lumen, preventing or limiting the ability to flush and/or administer solutions through a lumen or withdraw blood³.

Dislodgement

When the chosen securement method fails, and the catheter becomes displaced.

Extravasation

Inadvertent leakage of a vesicant solution into surrounding tissue⁴.

_{The BD Nexiva™ Closed Peripheral IV Catheter System is the only all-in-one PIVC shown to preserve sites for longer.^1* Its unique design can help to reduce complications, dwell longer, and preserve sites.}

Learn more through the pages below.

How prevalent are Peripheral IV Catheter complications?

Peripheral IV Catheter (PIVC) complications cause multiple restarts that affect everyone and everything, in almost every department. Additionally, IV catheters without blood control are still in use today.

Preserve sites and protect veins

Each time the PIVC is manipulated there is a risk of blood exposure and a greater chance of patient complications. Learn more about the various Vascular Access Device (VAD) guidelines and standards of practice.

Discover how an Integrated PIVC can save time (and money!)

Each department can have different clinical needs and components may need to be discarded and added throughout the journey, adding to your costs.

Learn how to insert the BD Nexiva™

Canadian Vascular Access & Infusion Therapy Guidelines² Infusion Therapy Standards of Practice (from Infusion Nurses Society)³

Canadian Vascular Access & Infusion Therapy Guidelines²

• Use extension set (integrated preferred) on PVAD (to reduce manipulations and avoid dislodgement).

• Use suture-less securement (including engineered securement devices) to limit movement of VAD. Method of securement can include an integrated stabilization feature on PVAD.

• Use safety-engineered medical sharps.

• Consider using sterile techniques for all PVAD insertions.

• Do not remove VAD based solely on length of dwell time, as optimum dwell time is unknown.

Placeholder

Preserving sites and protecting veins

The BD Nexiva™ closed IV catheter system is the only all-in-one PIVC system shown to preserve sites for longer¹

6 days versus 4 days median dwell time versus an open system studied in a randomized trial of PIVCs in place for more than 24 hours¹
May reduce delays in treatment and costs^1,2
Makes treating patients safer, compliant with standards and guidelines^1,2,3,4

Placeholder

_{BD Nexiva™ closed IV catheter system has features that help provide significantly better care}

Case study: Vancouver General Hospital

"Our cost/benefit analysis supported adoption of the BD Nexiva™ closed IV system. Its built-in stabilization platform reduces dislodgement and the attached extension set both eliminates manipulations at the hub and reduces blood exposure during insertion”
—Erin Davidson, RN, BSN, CVAA(c)

Learn how BD Nexiva™ can make your IV practice safer for yourself and your patients.
Opt-in below to get connected with a BD sales representative and/or to learn more about this technology:

NOTES & REFERENCES

Closed system = Fully-integrated system that consists of an integrated extension tube, stabilization platform, and needle-free connectors.
*Compared to an open system.
†When used with an IV site securement dressing.
‡Compared with B. Braun Introcan Safety® catheter with Bard Statlock® IV Ultra stabilization device.
§Compared with an FEP catheter

1. González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-126.
2. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheterstabilization systems. J Infus Nurs. 2010;33(6):371-384.
3. Canadian Vascular Access Association. (2019). Canadian Vascular Access and Infusion Therapy Guidelines. Pembroke, ON: Pappin Communications.
4. Gorski LA, Hadaway L, Hagle ME, et al. Infusion therapy standards of practice. J Infus Nurs. 2021;44(suppl 1):S1-S22
5. van Loon FH, Timmerman R, den Brok GP, Korsten EH, Dierick-van Daele AT, Bouwman AR. The impact of a notched peripheral intravenous catheter on the first attempt success rate in hospitalized adults: Block-randomized trial. The Journal of Vascular Access. 2022;23(2):295-303.
6. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Ann Intern Med. 1991;114(10):845-85

BD is committed to keeping your personal data protected and secure. More information on how we protect your personal data can be found in our privacy statement and our cookie policy.

Compliance with best practices around PIVC use may help increase patient satisfaction, limit resource utilization, and reduce costs ^3-7.

The BD Nexiva™ Closed Peripheral IV Catheter System is the only all-in-one PIVC shown to preserve sites for longer ^8*. Learn more about the catheter’s unique design and how it can help to reduce complications, dwell longer, and preserve sites. BD Nexiva™ is a passive-safety device with blood containment technology (thanks to its integrated extension set!), designed to protect the healthcare worker.